Estrogen effect on heart rate variability in hypertensive postmenopausal women

Maturitas

Volumn 44, Issue 1, 2003, Pages 39-48

  Brito Zurita, Olga Rosa ^a   Posadas Romero, Carlos ^b   Hermosillo, Antonio G ^b   Zamora González, José ^b   Hernández Ono, Antonio ^c   Cardoso Saldaña, Guillermo ^b   Torres Tamayo, Margarita ^c  

^a HOSPITAL DE CARDIOLOGÍA   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Estrogen replacement therapy; Heart rate variability; Hypertension; Postmenopausal women

Indexed keywords

CHOLESTEROL; CONJUGATED ESTROGEN; GLUCOSE; INSULIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; VERAPAMIL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; MULTIPLE REGRESSION; OUTCOMES RESEARCH; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SPECTROSCOPY; STATISTICAL ANALYSIS; TIME;

AGED; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY, AMBULATORY; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MIDDLE AGED; POSTMENOPAUSE; REGRESSION ANALYSIS; VERAPAMIL;

EID: 0037472857     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(02)00294-3     Document Type: Article

References (37)

1. Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 2000. p. 1-32.
2. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 273:1995;199-208.
3. Lindheim S.R., Buchanan T.A., Duffy D.M., et al. Comparison of estimates of insulin sensitivity in pre- and post-menopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test. J. Soc. Gynecol. Invest. 1:1994;150-154.
4. Vongpatanasin W., Tucenl M., Mansour Y., Arbique D., Victor R.G. Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women. Circulation. 103:2001;2903-2908.
5. Haarbo J., Marslew U., Gotfredsen A., Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism. 40:1991;1323-1326.
6. Lieberman E.H., Gerhard M.D., Uehata A., et al. Estrogen improves endothelium-dependent, flow-mediated vasodilatation in postmenopausal women. Ann. Intern. Med. 121:1994;936-941.
7. Bush D.E., Jones C.E., Bass K.M., Walters G.K., Briza J.M., Ouyang P. Estrogen replacement reverses endothelial dysfunction in postmenopausal women. Am. J. Med. 104:1998;552-558.
8. Guetta V., Quyyumi A.A., Prasad A., Panza J.A., Waclawiw M., Cannon R.O. The role of nitric oxide in coronary vascular effects in postmenopausal women. Circulation. 96:1997;2795-2801.
9. Lombardi F., Malliani A., Pagani M., Cerutti S. Heart rate variability and its sympatho-vagal modulation. Cardiovasc. Res. 32:1996;208-216.
10. Heart rate variability: standards of measurements, physiological interpretation, and clinical use. Circulation. 93:1996;1043-1045.
11. Malliani A., Pagani M., Lombardi F. Physiology and clinical implications of variability of cardiovascular parameters with focus on heart rate and blood pressure. Am. J. Cardiol. 73:1994;3c-9c.
12. Guzzetti S., Piccaluga E., Casati R., Cerutti S., Lombardi F., Pagani M., et al. Sympathetic predominance in essential hypertension: a study employing spectral analysis of heart rate variability. J. Hypertens. 6:1988;711-717.
13. Rosano G.M.C., Patrizi R., Leonardo F., et al. Effect of estrogen replacement therapy on heart rate variability and heart rate in healthy postmenopausal women. Am. J. Cardiol. 80:1997;815-817.
14. Mercuro G., Podda A., Pitzalis L., et al. Evidence of a role of endogenous estrogen in the modulation of autonomic nervous system. Am. J. Cardiol. 85:2000;787-789.
15. Arroyo P., Loría A., Fernández V., Flegal K.M., et al. Prevalence of pre-obesity and obesity in urban adult Mexicans in comparison with other large surveys. Obes. Res. 8:2000;179-185.
16. Joint National Committee on Detection Evaluation, and Treatment of High Blood Pressure. The Sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch. Intern. Med. 1997;157:2413-46.
17. Fauchier L., Babulty D., Autret M.L., Cosnay P., Fauchier J.P. Effect of verapamil on heart rate variability in subjects with normal hearts. Am. J. Cardiol. 80:1997;1234-1235.
18. De Long D.A., De Long A.R., Weed P.D. A comparison of methods for estimation of plasma low and very low density lipoprotein cholesterol. JAMA. 286:1986;2372-2374.
19. Kleiger R., Stein P., Bosnei M., Rottman J. Time domain measurements of heart rate variability. Cardiol. Clin. 10:1992;487-498.
20. Brovelli M., Baselli G., Cerutti S., Guzetti S., Liberety D., Lombardi F. Computerized analysis for an experimental validation of neurophysiological models of heart rate control. Comput. Cardiol. 2:1983;205-208.
21. Pinar E., Garcia-Alberola A., Llamas C., et al. Effects of verapamil on indexes of heart rate variability after acute myocardial infarction. Am. J. Cardiol. 81:1998;1085-1088.
22. Yildirir A., Kabakci G., Akgul E., Tokgozoglu L., Oto A. Effects of menstrual cycle on cardiac autonomic innervation as assessed by heart rate variability. Ann. Noninvasive Electrocardiol. 7:2002;60-63.
23. Niskanen L., Laitinen T., Tuppurainen M., Saarikoski S., Kröger H., Alhava E., et al. Does postmenopausal hormone replacement therapy affect cardiac autonomic regulation in osteoporotic women? Menopause. 9:2002;52-57.
24. Akahoshi M., Soda M., Nakashima E., Shimaoka K., Seto S., Yano K. Effects of menopause on trends of serum cholesterol, blood pressure and body mass index. Circulation. 94:1996;61-66.
25. Mathews K.A., Wing R.R., Kuller L.H., Meilahn E.N., Plantinga P. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. Arch. Intern. Med. 154:1994;2349-2355.
26. Kupari M., Virolainen J., Koskinen P., Tikkanen M. Short-term heart rate variability and factors modifying the risk of coronary artery disease in a population sample. Am. J. Cardiol. 72:1993;897-903.
27. Walton C., Godsland I.F., Proudler A.J., Wynn V., Stevenson J.C. The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese healthy women. Eur. J. Clin. Invest. 23:1993;466-473.
28. Reaven G.M., Lithel H., Lansberg L. Hypertension and associated metabolic abnormalities the role of insulin resistance and the sympathoadrenal system. N. Engl. J. Med. 334:1996;374-381.
29. Gao Y.Y., Lovejoy J.C., Sparti A., Bray G.A., Keys L.K., Partington C. Autonomic activity assessed by heart rate spectral analysis varies with fat distribution in obese women. Obes. Res. 4:1996;55-63.
30. Notelovitz M. Carbohydrate metabolism in relation to hormonal replacement therapy. Acta Obstet. Gynecol. Scand. 106:(Suppl):1982;51-56.
31. Simerly R.B., Chang C., Muramatsu M., Swanson L.W. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol. 294:1990;76-95.
32. Weiner C.P., Lizasoain I., Baylis S.A., Knowles R.G., Charles I.G., Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc. Natl. Acad. Sci. USA. 91:1994;5212-5216.
33. Lloyd T., Weisz J. Direct inhibition of tyrosine hydroxylase activity by catechol estrogens. J. Biol. Chem. 253:1978;4841-4843.
34. Lindheim S.R., Legro R.S., Bernstein L., et al. Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. Am. J. Obstet. Gynecol. 167:1992;1831-1836.
35. Loy R., Sheldon R.A. Sexually dimorphic development of cholinergic enzymes in the rat septohippocampal system. Dev. Brain Res. 34:1987;156-160.
36. Kaufman H., Vadasz C., Lajtha A. Effects of estradiol and dexamethasone on choline acetiltransferase activity in various rat brain regions. Brain Res. 453:1988;389-392.
37. 2 in porcine coronary artery. Circulation. 91:1995;2619-2626.